Inpatient and Outpatient Orderable

Lysosomal Acid Lipase Activity, Blood

Synonyms

LAB10855
LYSOAL
LYSOSOMAL ACID LIPASE ACTIVITY, BLD

Cerner Name

Clinical Info

Lysosomal acid lipase deficiency (LAL-D) is a lipid storage disorder with two clinically distinct phenotypes, Wolman disease (WD) and cholesteryl ester storage disease (CESD).
The LAL-D test is used to evaluate patients with a clinical presentation suggestive of lysosomal acid lipase deficiency and support a diagnosis of disease.

Specimen Sources

Blood, Arterial Blood, Capillary Blood, Central Line Blood, Venous

Specimen Types

Blood

Specimen Volume

3 mL whole blood (0.5 mL min)

Container

Lavender Top Tube

Collection Instructions

Container/Tube: Lavender EDTA tube
Specimen: 3 mL whole blood (0.5 mL min)
Transport Temperature: Frozen
Stability: 7 Days Room Temperature
14 Days Refrigerated
28 Days Frozen

Transport Instructions

Frozen

Specimen Stability

7 Days Room Temperature
14 Days Refrigerated
28 Days Frozen

Methodology

Fluorometric Enzyme Assay This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.

Days Performed

Tuesday

TAT 6 - 14 Days

Performing Laboratory

Quest Diagnostics' Nichols Institute, Inc. - Chantilly

CPT

82657

LOINC Code: 73958-1

PDM

1859709

Only Orderable at Locations:

Orderable Everywhere

Results

Component Name	Base Name	Common Name	External Name
LYSOSOMAL ACID LIPASE	LYSOSOMALAC	LYSOSOMAL ACID LIPASE	Lysosomal Acid Lipase
LYSOSOMAL ACID LIPASE INTERPRETATION	LYSOSOMALAC	LYSOSOMAL ACID LIPASE INTERPRETATION	Lysosomal Acid Lipase Interpretation

Result Interpretation

69 - 203 pmol/hr/uL

Forms

LAB10855

Search: .supercomplete-item { width: 600px; white-space: nowrap; overflow: hidden; text-overflow: ellipsis; } $(document).ready(function() { $("#search_input").supercomplete(); });